Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival : Analysis of the National Cancer Database
Abstract Background Adult head and neck (H&N) sarcomas are a rare malignancy with limited data delineating the role of postoperative radiotherapy (PORT), particularly for a positive surgical margin. There are no randomized trials supporting the use of PORT, therefore treatment trends vary between institutions. A positive margin predicts recurrence and poor survival outcomes. This study uses the National Cancer Database (NCDB) to investigate whether PORT improves overall survival (OS) in adult H&N sarcomas with a positive margin and how utilization has changed. Methods Patients ( n = 1142) in the NCDB from 2004‐2013 with adult H&N sarcomas who underwent resection and had a positive margin. Results Factors significantly associated with increased utilization of PORT were: having insurance, salivary gland primary site, high‐risk histology, poor differentiation, and a macroscopic positive margin. Treatment with PORT was associated with improved 5‐year OS for all patients with a positive margin (57% vs 48%; P = .002), both microscopic (57% vs 49%; P = .010) and macroscopic (57% vs 41%; P = .036). Improved OS was significant after controlling for other known covariates on multivariate analysis (HR: 0.76; [0.64‐0.90]; P = .002). Treatment at a community‐based facility was an independent predictor for reduced OS (HR: 1.37; [1.15‐1.64]; P < .001). The percentage utilization (53%) of PORT for these patients did not change significantly over time. Conclusion PORT provides a significant survival benefit for adult H&N sarcoma patients with either a microscopic or macroscopic positive margin; however, PORT is underutilized. Treatment at academic/research cancer programs was associated with increased utilization of PORT and improved survival outcomes..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Head & Neck - 41(2019), 6, Seite 1873-1879 |
Beteiligte Personen: |
Cannon, Richard B. [VerfasserIn] |
---|
BKL: |
---|
Anmerkungen: |
© 2019 Wiley Periodicals, Inc. |
---|
Umfang: |
7 |
---|
doi: |
10.1002/hed.25619 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
WLY006990061 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | WLY006990061 | ||
003 | DE-627 | ||
005 | 20230307164520.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230216s2019 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1002/hed.25619 |2 doi | |
028 | 5 | 2 | |a HED_HED25619.xml |
035 | |a (DE-627)WLY006990061 | ||
035 | |a (WILEY)HED25619 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.83 |2 bkl | ||
084 | |a 44.94 |2 bkl | ||
100 | 1 | |a Cannon, Richard B. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival |b Analysis of the National Cancer Database |
264 | 1 | |c 2019 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © 2019 Wiley Periodicals, Inc. | ||
520 | |a Abstract Background Adult head and neck (H&N) sarcomas are a rare malignancy with limited data delineating the role of postoperative radiotherapy (PORT), particularly for a positive surgical margin. There are no randomized trials supporting the use of PORT, therefore treatment trends vary between institutions. A positive margin predicts recurrence and poor survival outcomes. This study uses the National Cancer Database (NCDB) to investigate whether PORT improves overall survival (OS) in adult H&N sarcomas with a positive margin and how utilization has changed. Methods Patients ( n = 1142) in the NCDB from 2004‐2013 with adult H&N sarcomas who underwent resection and had a positive margin. Results Factors significantly associated with increased utilization of PORT were: having insurance, salivary gland primary site, high‐risk histology, poor differentiation, and a macroscopic positive margin. Treatment with PORT was associated with improved 5‐year OS for all patients with a positive margin (57% vs 48%; P = .002), both microscopic (57% vs 49%; P = .010) and macroscopic (57% vs 41%; P = .036). Improved OS was significant after controlling for other known covariates on multivariate analysis (HR: 0.76; [0.64‐0.90]; P = .002). Treatment at a community‐based facility was an independent predictor for reduced OS (HR: 1.37; [1.15‐1.64]; P < .001). The percentage utilization (53%) of PORT for these patients did not change significantly over time. Conclusion PORT provides a significant survival benefit for adult H&N sarcoma patients with either a microscopic or macroscopic positive margin; however, PORT is underutilized. Treatment at academic/research cancer programs was associated with increased utilization of PORT and improved survival outcomes. | ||
700 | 1 | |a Kull, Amanda J. |4 aut | |
700 | 1 | |a Carpenter, Patrick S. |4 aut | |
700 | 1 | |a Francis, Sam |4 aut | |
700 | 1 | |a Buchmann, Luke O. |4 aut | |
700 | 1 | |a Monroe, Marcus M. |4 aut | |
700 | 1 | |a Lloyd, Shane |4 aut | |
700 | 1 | |a Hitchcock, Ying J. |4 aut | |
700 | 1 | |a Cannon, Donald |4 aut | |
700 | 1 | |a Weis, John R. |4 aut | |
700 | 1 | |a Houlton, Jeffrey J. |4 aut | |
700 | 1 | |a Hunt, Jason P. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Head & Neck |g 41(2019), 6, Seite 1873-1879 |w (DE-627)WLY006984223 |x 10970347 |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2019 |g number:6 |g pages:1873-1879 |g extent:7 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_WLY | ||
936 | b | k | |a 44.83 |q ASE |
936 | b | k | |a 44.94 |q ASE |
951 | |a AR | ||
952 | |d 41 |j 2019 |e 6 |h 1873-1879 |g 7 |